Principe du test
Ceramide ELISA Kit (A326471) employs the competitive enzyme immunoassay technique for the quantitative measurement of Ceramide in serum, plasma, cell culture supernatant, cell or tissue lysate, and other liquid samples. The 96-well microtiter plate has been pre-coated with Ceramide antigen. During the incubation, Ceramide present in the samples or standards competes with the fixed amount of immobilized Ceramide for binding sites on the Biotinylated Anti-Ceramide Antibody. The more Ceramide present in a sample or standard, the less Biotinylated Anti-Ceramide Antibody that binds to the plate. Following incubation, unbound Biotinylated Anti-Ceramide Antibody is removed by washing, and an HRP-Streptavidin conjugate is added to the wells and the microtiter plate is incubated. Following incubation and washing, TMB substrate solution is then used to visualize the HRP enzymatic reaction by catalysis to produce a blue-coloured product that changes to yellow after addition of acidic stop solution. The density of yellow is inversely proportional to the amount of Ceramide present in each sample or standard. The concentration of Ceramide can then be calculated by reading the O.D. absorbance at 450nm in a microplate reader and referring to the standard curve.